Nachrichten zur Moderna Inc. Aktie

Why Moderna Stock Dropped on Thursday

Moderna promised 20% sales growth in 2026 -- but Wall Street wants 24%.…

Why Moderna Stock Dropped on Thursday

Moderna promised 20% sales growth in 2026 -- but Wall Street wants 24%.…

Moderna Aktie: Krebs-Pipeline macht Hoffnung – Kursziel steigt auf 195 USD

Goldman Sachs erhöht das Moderna-Kursziel auf 195 USD, während starke Quartalszahlen und die Krebs-Pipeline Zuversicht wecken.…

Moderna Aktie: Zahlen überzeugen – Finanzierungsdebatte verliert an Schärfe

BofA erhöht das Moderna-Kursziel auf 260 USD und sieht im Krebsmittel Intismeran den entscheidenden kurzfristigen Kurstreiber.…

Modernas Q3 Numbers May Have Seemed Impressive, but They Arent Enough to Make the Stock a Buy

Revenue for the vaccine maker rose sharply in the third quarter, but it was largely due to COVID sales, which…

Can Modernas First Cancer Therapy Win FDA Approval in 2027?

MRNA targets a year-end 2026 FDA filing for its personalized cancer therapy, intismeran, potentially paving the way for a regulatory…

Moderna Aktie: Kühlen Kopf bewahren - dank Money Management

Moderna nimmt nach über 700% Kursplus die Marke von 300 USD ins Visier, doch überkaufte Indikatoren mahnen zur Vorsicht.…

Heres how to buy and sell stocks like a member of Congress

Modern online portals allow everyday investors to buy and sell the same stocks favored by Congress. Does the strategy work?…

Healthcare Stocks Were Flat, But Biotech Found A Pulse

Moderna raised its full-year outlook as Natera slid on a wider-than-expected Q3 loss and Hims & Hers gained on a…

Moderna (MRNA) Stock Hits 52-Week Highs After Q3 Earnings: Buy, Hold, or Sell?

Moderna stock has surged as much as 10% in Fridays trading session, reaching a fresh 52-week high after delivering much…

Stocks making the biggest moves midday: Nvidia, Moderna, IonQ, Airbnb, Firefly Aerospace & more

Here are some of the companies making headlines in midday trading.…

MRNA Q3 Earnings Beat on COVID Sales, Raises 26 Outlook, Stock Rises

Modernas Q3 earnings beat estimates on strong COVID-19 vaccine sales, returning to profitability and boosting its 2026 revenue growth outlook.…

Stocks making the biggest moves premarket: Moderna, Airbnb, Cloudflare, Affirm & more

These are some of the stocks posting the largest moves premarket.…

Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction

The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to…

Moderna shares surge 10% on earnings beat and raised revenue outlook

Moderna shares surge 10% on earnings beat and raised revenue outlook…

Moderna lifts annual revenue forecast on strong COVID vaccine demand overseas

Moderna lifts annual revenue forecast on strong COVID vaccine demand overseas…

Moderna shares jump as earnings beat prompts higher 2026 sales outlook

Moderna Inc (NASDAQ:MRNA, XETRA:0QF) shares rose 7% to $259 as the biotechnology company beat third-quarter earnings and revenue estimates and raised…

Scottish Mortgage NAV total return rises 31.5% as SpaceX listing and Moderna trial success lift performance

Scottish Mortgage Investment Trust PLC (LSE:SMT), managed by Baillie Gifford, delivered a net asset value (NAV) total return of 31.5%…

Moderna kommt personalisierter Krebstherapie näher

Moderna entwickelt Impfstoffe und Medikamente auf Basis der Boten-RNA. Diese liefert Körperzellen eine Bauanleitung für Proteine, mit denen das Immunsystem…

Could Investing in Modernas Stock Double Your Money?

The healthcare stock has generated massive returns this year and may still have room to rise even higher in the…

If Modernas CEO Is Right, the Stocks Rally Could Just Be Getting Started

Stéphane Bancel has high hopes for the companys cancer vaccine, beyond just treating melanoma.…

Micron geschlagen, Nvidia distanziert: Moderna-Aktie mit unglaublicher Jahresperformance – und nun?

Die Moderna-Aktie hat in diesem Jahr dreistellig zugelegt und Schwergewichte wie Nvidia und Micron Technology distanziert. KI-Werte trieben den S&P…

Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to Know

Moderna (MRNA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware…

Breakthrough cancer vaccine catches Wall Streets attention

Moderna and Mercks trial results in melanoma thrilled oncologists. Shareholders, however, felt differently.…

Moderna Aktie: Droht trotz Krebsimpfstoff-Hoffnung jetzt die große Ernüchterung?

Chicago (www.aktiencheck.de) - Moderna-Aktienanalyse von William Blair & Co:William Blair habe die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9,…

Moderna Aktie: Krebsstudie liefert Daten mit Meilenstein-Potenzial

Minneapolis (www.aktiencheck.de) - Moderna-Aktienanalyse von Piper Sandler:Die Analysten von Piper Sandler erhöhen das Kursziel für die Aktie von Moderna Inc.…

Schlussglocke: KI-Aktien stark, Tesla zieht kräftig an – Verizon, Moderna und Merck & Co unter Druck

Starker Wochenstart an der Wall Street. Die wichtigsten US-amerikanischen Indizes konnten am Montag deutliche Zugewinne verbuchen. Vor allem KI-Aktien zeigten…

Moderna-Aktie schwächer: Warum starke Krebsdaten den Kurs nicht tragen - BioNTech in Rot

Starke Studiendaten treffen auf einen Kursrutsch bei ModernaAnalysten bleiben bei Moderna in ihren Einstufungen weit auseinanderBioNTech verbucht Rückschläge und Fortschritte…

Moderna Aktie: Schockzustand

New York (www.aktiencheck.de) - Moderna-Aktienanalyse der Citigroup:Der Citi-Analyst Geoff Meacham habe das "sell"-Rating für die Aktie von Moderna Inc. (ISIN:…

Stocks making the biggest moves premarket: Verizon, Tesla, Moderna & more

These are the stocks posting the largest moves premarket.…

Notable healthcare headlines for the week: Moderna, Roche, and Abbott Laboratories in focus

…

Moderna Aktienanalyse: Kursziel 55% unter Schlusskurs - wie überzeugend sind die Krebsdaten?

Bad Marienberg (www.aktiencheck.de) - Vielversprechende Studiensignale, unbestätigte Informationen und ein Kursziel weit unter dem Börsenkurs: Die Moderna-Aktienanalyse von TD Cowen…

Moderna stock extends losses as investors digest melanoma vaccine trial data

Moderna shares ended Friday’s session modestly lower, extending the sharp losses recorded in the previous trading sessions.…

Doctors call Moderna, Merck cancer vaccine data a major advancement — despite Wall Street reaction

Six melanoma specialists said the Moderna and Merck vaccine results represent a clinically meaningful result for melanoma patients who underwent…

Moderna trims losses as investors digest melanoma vaccine trial data

Moderna stock stabilized on Friday, reversing the prior sessions steep sell-off.…

Stocks making the biggest moves premarket: AT&T, SpaceX, Moderna, Deckers, Bloom Energy and more

These are the stocks posting the largest moves in early trading.…

Inside biotech: Personalised mRNA cancer vaccine cuts melanoma recurrence risk by 42% in Phase 3 trial

A personalised mRNA cancer vaccine jointly developed by Moderna Inc (NASDAQ:MRNA, XETRA:0QF) and MSD (Unlisted (UK):MSD) has reduced the risk of…

Wall Street Breakfast Podcast: Modernas Good News Goes Bad

…

25 Prozent im Minus: Krebs-Impfstoff erfolgreich - Moderna-Aktie bricht trotzdem ein

Eine groß angelegte Patientenstudie bestätigt das hohe Potenzial personalisierter Immuntherapien gegen Hautkrebs. Trotz der überzeugenden Studienergebnisse beim Melanom gerät die Aktie…

Moderna stock’s 17% slump was a ‘sell the news’ event, analyst says

Moderna shares tumbled after leaked cancer vaccine trial data showed promising results for its treatment developed with Merck.…

Moderna plunges on leaked vaccine data, Musk to invest $1B in Skydance, Spotify surges

Market Domination Host Brooke DiPalma tracks several of the days top trending stock tickers, including Moderna (MRNA) plunging after the…

Pharma: Krebsimpfstoff-Daten von Moderna und Merck vorzeitig veröffentlicht – Aktien fallen

Vorzeitig bekannt gewordene Studiendaten zu einem Krebsimpfstoff setzen Moderna und Merck & Co. unter Druck. Zeitweise verlor die Moderna-Aktie bis…

Moderna shares plunge after leak of cancer vaccine data despite positive results

Modernas stock fell even though the full data, released later Thursday, appeared positive based on Wall Street expectations ahead of…

Moderna shares plunge on apparent cancer vaccine data leak

Moderna shares plunge on apparent cancer vaccine data leak…

Moderna (MRNA) Rises Higher Than Market: Key Facts

The latest trading day saw Moderna (MRNA) settling at $245.81, representing a +1.54% change from its previous close.…

Why is Moderna stock rallying today?

Why is Moderna stock rallying today?…

Move Aside, Moderna: This mRNA Stock Is Sitting on a Cash Pile and a Deep Cancer Pipeline

BioNTech has billions in cash, and its oncology programs are moving into late-stage clinical trials.…

Moderna stock sinks as Wall Street turns cautious following blistering rally

Moderna sank as Wall Street grew more cautious on the companys valuation after a massive rally this year.…

MRNA Stock Gains Over $4B in a Week: Time to Buy, Hold or Sell?

Moderna gains $4.2 billion in a week on cancer-vaccine optimism and Nasdaq-100 inclusion. Can its growth prospects justify its premium…

Moderna vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?

Vertex raised its full-year outlook in Q2 with a growing pipeline across multiple disease areas. Moderna’s mRNA flu vaccine just…